データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
10-Q:Q3 2024 四半期報告書
10-Q/A:四半期報告書(訂正)
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements
10-Q:Q2 2024 四半期報告書
Powerup Acquisition Signs Letter of Intent for a Potential Merger With Aspire Biopharma
Aspire Biopharma and PowerUp Intend to Finalize Business Combination in Coming Weeks and Will Give Additional Details at That Time